nanomed-alliance.com
Unit 1: Liposomal Devices
http://www.nanomed-alliance.com/participants/nanocan-team/unit-1-liposomal-devices
Aptamers, RNAi / Chimeras. Validation, Discovery, Tools. Unit 1: Liposomal Devices. Unit 4: Cellular Models. Unit 5: Robotic Screens. Unit 6: Preclinical Validation. Unit 1: Liposomal Devices. Unit 1: Liposomal Devices. Unit 1: Liposomal Devices. Anders H. Hansen. Thomas E. Rasmussen.
nanomed-alliance.com
HT-Screens
http://www.nanomed-alliance.com/background/division-3-ht-screens
Aptamers, RNAi / Chimeras. Validation, Discovery, Tools. Unit 1: Liposomal Devices. Unit 4: Cellular Models. Unit 5: Robotic Screens. Unit 6: Preclinical Validation. Division 3: HT Screens. Head: Prof. Jan Mollenhauer. NanoCAN's DIVISION 3 represents the the central platform of the center for the construction of advanced cell models ( Unit 4. Unit 4: Cellular Models. Synthetic Lethal Pilot Project. Construction of Synthetic Cancer Stem Cells. CSC Marker Detection via Biochips.
nanomed-alliance.com
NanoCAN Team
http://www.nanomed-alliance.com/participants/nanocan-team
Aptamers, RNAi / Chimeras. Validation, Discovery, Tools. Unit 1: Liposomal Devices. Unit 4: Cellular Models. Unit 5: Robotic Screens. Unit 6: Preclinical Validation. The NanoCAN Team consists of Bachelor-, Master- and PhD students, as well as Post Docs working on different projects described in Overview. Unit 1: Liposomal Devices. Unit 2: Aptamers and RNAi / Chimeras. Unit 3: Non-Liposomal Nanospheres. Unit 4: Cellular Models. Unit 5: Robotic Screens. Unit 6: Preclinical Validation.
nanomed-alliance.com
Overview
http://www.nanomed-alliance.com/background/overview
Aptamers, RNAi / Chimeras. Validation, Discovery, Tools. Unit 1: Liposomal Devices. Unit 4: Cellular Models. Unit 5: Robotic Screens. Unit 6: Preclinical Validation. NanoCAN is substructured into four divisions, including eight research units with respective projects to accomplish its goals. The chart below displays the center`s organization. To learn more about the objectives and activities of each project click on the unit in the chart. The research activities are located in DIVISION 2-4. DIVISON 2.
nanomed-alliance.com
Transcriptomics & Bioinform.
http://www.nanomed-alliance.com/background/division-4-validation-discovery-and-tools/unit-7-transcriptomics-a-bioinformatics
Aptamers, RNAi / Chimeras. Validation, Discovery, Tools. Unit 1: Liposomal Devices. Unit 4: Cellular Models. Unit 5: Robotic Screens. Unit 6: Preclinical Validation. Validation, Discovery, Tools. Unit 7: Transcriptomics and Bioinformatics. Unit 7: Transcriptomics and Bioinformatics. The origin of our data. Statistical methods allow for Quality Control and help to assess significance. What happens with the results? Approximately 20,000 genes are sequentially silenced in a genome wide siRNA screen. The...
nanomed-alliance.com
Cellular Models
http://www.nanomed-alliance.com/background/division-3-ht-screens/unit-4-cellular-models
Aptamers, RNAi / Chimeras. Validation, Discovery, Tools. Unit 1: Liposomal Devices. Unit 4: Cellular Models. Unit 5: Robotic Screens. Unit 6: Preclinical Validation. Unit 4: Cellular Models. Synthetic Lethal Pilot Project. Construction of Synthetic Cancer Stem Cells. CSC Marker Detection via Biochips. Construction of Synthetic Cancer Stem Cells. CSC Marker Detection via Biochips. Synthetic Lethal Pilot Project.
nanomed-alliance.com
Topics
http://www.nanomed-alliance.com/background
Aptamers, RNAi / Chimeras. Validation, Discovery, Tools. Unit 1: Liposomal Devices. Unit 4: Cellular Models. Unit 5: Robotic Screens. Unit 6: Preclinical Validation. NanoCAN is substructured into four divisions, including eight research units with respective projects to accomplish its goals. The chart below displays the center`s organization. To learn more about the objectives and activities of each project click on the unit in the chart. The research activities are located in DIVISION 2-4. DIVISON 2.
nanomed-alliance.com
Management
http://www.nanomed-alliance.com/background/division-1-management
Aptamers, RNAi / Chimeras. Validation, Discovery, Tools. Unit 1: Liposomal Devices. Unit 4: Cellular Models. Unit 5: Robotic Screens. Unit 6: Preclinical Validation. Head: Prof. Jan Mollenhauer. DIVISION 1 coordinates the activities of NanoCAN with regards to. Cooperation with other initiatives and centers. The management board of NanoCAN is comprised of.
nanomed-alliance.com
Nanoparticles
http://www.nanomed-alliance.com/background/division2
Aptamers, RNAi / Chimeras. Validation, Discovery, Tools. Unit 1: Liposomal Devices. Unit 4: Cellular Models. Unit 5: Robotic Screens. Unit 6: Preclinical Validation. Heads: Prof. Jesper Wengel. And Prof. Ole Mouritsen. DIVISION 2 pursues three basic strategies to improve the situation:. Deals with liposomal delivery formats, building up on basic research performed in the Center of Excellence MEMPHYS. Explores alternative delivery formats, which are of synthetic or natural origin. Unit 1: Liposomal Devices.
nanomed-alliance.com
Validation, Discovery, Tools
http://www.nanomed-alliance.com/background/division-4-validation-discovery-and-tools
Aptamers, RNAi / Chimeras. Validation, Discovery, Tools. Unit 1: Liposomal Devices. Unit 4: Cellular Models. Unit 5: Robotic Screens. Unit 6: Preclinical Validation. Validation, Discovery, Tools. Division 4: Validation, Discovery and Tools. Head: Prof. Henrik Ditzel. NanoCAN s DIVISION 4 constitutes the platform for preclinical validation in primary cells and mouse models ( Unit 6. As well as for discovery approaches of new potential markers and drug targets by transcriptomics ( Unit 7. UNIT 7 employs ex...
